About Helix Ventures
Helix Ventures is a venture capital firm founded in 2008. It is primarily based out of Palo Alto, United States. It primarily invests in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Overall, Helix Ventures portfolio has seen 7 acquisitions including key companies like Invuity, MicroVention and iScience Interventional.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Portfolio Acquisitions
Helix Ventures' List of Top Investments
Helix Ventures has a portfolio of 13 companies. Their most notable investments include Proteus Digital Health and Invuity.Their portfolio spans across and United States. They have invested in Life Sciences, Enterprise Applications, HealthTech and 2 other sectors. Here is the list of top investments by Helix Ventures:Provider of cloud-based patient medication adherence monitoring system for the healthcare providers. The SaaS-based platform includes an ingestible sensor that gets activated on contact with stomach acid after ingestion and sends a signal to determine the identity and timing of ingestion to an adhesive patch stuck in the left upper quadrant of the abdomen.
Key facts about Proteus Digital Health
- Founded Year: 2001
- Location: Redwood City (United States)
- Valuation: $*****
- Stage: Series H
- Total Funding till date: $532M
- Employee Count: 61 as on Mar 31, 2026
- Investors: Adams Street Partners, Kaiser Permanente Ventures and 24 Others
- Latest Funding Round: Series H, Oct 11, 2018, $*****
- Highlight: Editors' Pick
2. Invuity
Invuity develops products using advanced photonics for direct visualization of surgical cavities during minimally invasive procedures. The products use a proprietary optical waveguide technology for illumination of the surgical target. Its stated application areas include orthopedic, spine, breast and thyroid surgeries. The company went public in June 2015.
Key facts about Invuity
- Founded Year: 2004
- Location: San Francisco (United States)
- Annual Revenue: $39.6M as on Dec 31, 2017
- Stage: Acquired
- Total Funding till date: $99.1M
- Employee Count: 139 as on Dec 31, 2018
- Investors: Wellington, Bering Capital and 12 Others
- Latest Funding Round: Series E, Mar 09, 2015, $*****
- Highlight: Acquired
3. MicroVention
Innovative neurovascular solutions for hemorrhagic and ischemic stroke treatment. They develop and market minimally invasive neuroendovascular technologies, offering therapeutic advantages for neurovascular disorders. Their comprehensive portfolio includes devices for treating aneurysms, neurovascular malformations, ischemic stroke, and carotid artery disease. They provide access products like catheters and guidewires. They focus on advancing physician practice and improving patient outcomes through innovation in neurovascular care. They are committed to creating technologies that improve patients' lives. They are a medical device company.
Key facts about MicroVention
- Founded Year: 1997
- Location: Tustin (United States)
- Annual Revenue: £16.6M as on Mar 31, 2025
- Stage: Acquired
- Employee Count: 2,066 as on Jan 28, 2025
- Investors: Domain Associates, Advanced Technology Ventures and 4 Others
- Highlight: Acquired
Innovative medical device company focused on interventional solutions. The company explores, illuminates, and delivers advanced technologies for medical interventions. They provide quality content and resources related to their field. The business model is centered around developing and distributing specialized medical devices. The company is likely operating in the B2B sector, providing tools and technologies to healthcare professionals. The focus is on improving patient outcomes through innovative interventional techniques. The company's offerings likely include a range of products or services designed to enhance the precision and effectiveness of medical procedures.
Key facts about iScience Interventional
- Founded Year: 1999
- Location: Menlo Park (United States)
- Stage: Acquired
- Total Funding till date: $36.7M
- Investors: Square 1 Bank, Pacific Horizon Ventures and 11 Others
- Latest Funding Round: Conventional Debt, May 08, 2012, $*****
- Highlight: Acquired
5. Biomimedica
Online casino bonuses and low minimum deposit options for players. This platform provides access to various online casinos with a focus on low minimum deposits, allowing players to enjoy casino games without significant financial commitment. It offers information on no deposit bonuses, free spins, and other promotional offers available at different casinos. The platform aims to create an accessible and affordable environment for both new and experienced gamblers. It also provides resources and information on responsible gambling, including links to support services. The site serves as a guide for players looking to explore online gambling with minimal initial investment, offering insights into different bonus types and strategies for managing bankrolls effectively.
Key facts about Biomimedica
- Founded Year: 2007
- Location: San Francisco (United States)
- Stage: Deadpooled
- Total Funding till date: $17.4M
- Employee Count: 1 - 10 as on Jul 01, 2024
- Investors: Emergent Medical Partners, Helix Ventures and 5 Others
- Latest Funding Round: Series B, Jul 02, 2014, $*****
Acquired companies in Helix Ventures' Portfolio
7 companies from Helix Ventures' portfolio have been acquired. The most recent acquisition was Invuity in Sep 2018 by Stryker for $*****.Here are Helix Ventures' portfolio companies that got acquired most recently:
Filter this listCompany | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Sep 11, 2018 | - | - | 5680 | |
Jul 01, 2017 | - | - | 7338 | |
Feb 01, 2014 | - | - | 7853 | |
Jan 20, 2014 | - | - | 5467 | |
Apr 15, 2009 | - | - | 8132 |
